Covered recipient · General Payments record
BAGI RP JANA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2023
$72,604.75
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,692.50 | 3 |
| Travel and Lodging | $780.88 | 4 |
| Honoraria | $360.00 | 1 |
| Food and Beverage | $237.59 | 4 |
| Education | $37.21 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $3,342.20 | 3 |
| Astellas Pharma US Inc | $2,699.82 | 5 |
| GENZYME CORPORATION | $1,638.57 | 2 |
| Daiichi Sankyo Inc. | $360.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $37.21 | 1 |
| ABBVIE INC. | $30.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.38 | 11/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997554965 | CMS |
| Astellas Pharma US Inc | $272.09 | 05/19/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1034115573 | CMS |
| Astellas Pharma US Inc | $30.00 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034168205 | CMS |
| Astellas Pharma US Inc | $2,100.00 | 06/13/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1034168235 | CMS |
| Astellas Pharma US Inc | $272.73 | 06/13/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1034168729 | CMS |
| Astellas Pharma US Inc | $25.00 | 06/13/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1034168741 | CMS |
| AstraZeneca Pharmaceuticals LP | $211.06 | 11/03/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1015725455 | CMS |
| AstraZeneca Pharmaceuticals LP | $48.64 | 11/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016146249 | CMS |
| AstraZeneca Pharmaceuticals LP | $3,082.50 | 11/22/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1014860409 | CMS |
| Daiichi Sankyo Inc. | $360.00 | 12/04/2023 | Honoraria | Undisputed | 01/23/2026 | 1006538047 | CMS |
| E.R. Squibb & Sons, L.L.C. | $37.21 | 08/21/2023 | Education | Undisputed | 01/23/2026 | 1015704089 | CMS |
| GENZYME CORPORATION | $128.57 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049757365 | CMS |
| GENZYME CORPORATION | $1,510.00 | 02/16/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1049757373 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.